Filed 3.5y ago· Dec 19, 2022
1083 days to disclose · 1038 past 45-day window
Thomas R. Suozzi
DHouseNew York-03
↑bought
Johnson & Johnson
JNJ
$15K-$50K
Trade dateJan 1, 2020
2000084479 Johnson & Johnson
⚑ Pharmaceutical
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 101–133 of 133
Filed 3.5y ago· Dec 12, 2022
34 days to disclose
Christopher L. Jacobs
RHouseNew York-27
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+21.3% vs S&P 500
Trade dateNov 8, 2022
Filed 3.6y ago· Nov 10, 2022
29 days to disclose
Kathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+20.3% vs S&P 500
Trade dateOct 12, 2022
Filed 3.6y ago· Nov 1, 2022
50 days to disclose · 5 past 45-day window
Lloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+26.6% vs S&P 500
Trade dateSep 12, 2022
⚑ Pharmaceutical
Filed 3.6y ago· Oct 11, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+26.6% vs S&P 500
Trade dateSep 12, 2022
Filed 3.7y ago· Sep 14, 2022
42 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+12.4% vs S&P 500
Trade dateAug 3, 2022
Filed 3.8y ago· Sep 2, 2022
296 days to disclose · 251 past 45-day window
Carol D. Miller
RHouseWest Virginia-01
↓sold
Johnson & Johnson
JNJ
$15K-$30K
+15.5% vs S&P 500
Trade dateNov 10, 2021
⚑ Pharmaceutical
Filed 3.8y ago· Aug 10, 2022
26 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+15.7% vs S&P 500
Trade dateJul 15, 2022
Filed 3.9y ago· Jul 11, 2022
31 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−51.3% vs S&P 500
Trade dateJun 10, 2022
⚑ Pharmaceutical
Filed 4.0y ago· Jun 9, 2022
29 days to disclose
Lois Frankel
DHouseFlorida-22
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+13.5% vs S&P 500
Trade dateMay 11, 2022
Filed 4.0y ago· Jun 9, 2022
45 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+10.4% vs S&P 500
Trade dateApr 25, 2022
Filed 4.0y ago· Jun 3, 2022
22 days to disclose
Cindy Axne
—HouseIowa-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+16.7% vs S&P 500
Trade dateMay 12, 2022
Filed 4.0y ago· Jun 3, 2022
30 days to discloseCindy Axne
—HouseIowa-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+11.9% vs S&P 500
Trade dateMay 4, 2022
Filed 4.0y ago· Jun 3, 2022
30 days to discloseCindy Axne
—HouseIowa-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+11.9% vs S&P 500
Trade dateMay 4, 2022
Filed 4.1y ago· Apr 19, 2022
34 days to disclose
John H. Rutherford
RHouseFlorida-05
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+10.8% vs S&P 500
Trade dateMar 16, 2022
Filed 4.6y ago· Oct 18, 2021
35 days to disclose
Robert J. Wittman
RHouseVirginia-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+12.2% vs S&P 500
Trade dateSep 13, 2021
Filed 4.6y ago· Oct 18, 2021
47 days to disclose · 2 past 45-day windowRobert J. Wittman
RHouseVirginia-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+9.8% vs S&P 500
Trade dateSep 1, 2021
Filed 4.7y ago· Oct 8, 2021
535 days to disclose · 490 past 45-day windowCindy Axne
—HouseIowa-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
Trade dateApr 21, 2020
Filed 4.7y ago· Oct 8, 2021
603 days to disclose · 558 past 45-day windowCindy Axne
—HouseIowa-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateFeb 13, 2020
Filed 4.7y ago· Oct 8, 2021
603 days to disclose · 558 past 45-day windowCindy Axne
—HouseIowa-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateFeb 13, 2020
Filed 4.7y ago· Oct 8, 2021
647 days to disclose · 602 past 45-day windowCindy Axne
—HouseIowa-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateDec 31, 2019
Filed 4.7y ago· Oct 8, 2021
813 days to disclose · 768 past 45-day windowCindy Axne
—HouseIowa-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateJul 18, 2019
Filed 4.7y ago· Oct 8, 2021
940 days to disclose · 895 past 45-day windowCindy Axne
—HouseIowa-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateMar 13, 2019
Filed 4.7y ago· Oct 7, 2021
30 days to disclose
Kevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+30.4% vs S&P 500
Trade dateSep 7, 2021
⚑ Pharmaceutical
Filed 4.7y ago· Sep 23, 2021
1387 days to disclose · 1342 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
Trade dateDec 6, 2017
⚑ Pharmaceutical
Filed 4.9y ago· Jul 17, 2021
44 days to disclose
Blake D. Moore
RHouseUtah-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+22.0% vs S&P 500
Trade dateJun 3, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 17, 2021
113 days to disclose · 68 past 45-day windowBlake D. Moore
RHouseUtah-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateMar 26, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 17, 2021
135 days to disclose · 90 past 45-day windowBlake D. Moore
RHouseUtah-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateMar 4, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 17, 2021
143 days to disclose · 98 past 45-day windowBlake D. Moore
RHouseUtah-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateFeb 24, 2021
⚑ Pharmaceutical
Filed 5.0y ago· Jun 12, 2021
30 days to disclose
Rick W. Allen
RHouseGeorgia-12
↓sold
Johnson & Johnson
JNJ
$15K-$30K
+40.2% vs S&P 500
Trade dateMay 13, 2021
⚑ Pharmaceutical
Filed 5.1y ago· May 9, 2021
16 days to disclose
Marie Newman
—HouseIllinois-03
↓sold
Johnson & Johnson
JNJ
$15K-$50K
Trade dateApr 23, 2021
Filed 5.1y ago· May 9, 2021
38 days to discloseMarie Newman
—HouseIllinois-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
Trade dateApr 1, 2021
Filed 5.1y ago· May 6, 2021
6 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$15K-$30K
−31.3% vs S&P 500
Trade dateApr 30, 2021
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↑bought | Johnson & Johnson JNJ 2000084479 Johnson & Johnson ⚑ Pharmaceutical · Ways and Means | Jan 1, 2020 1083 days to disclose · 1038 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Dec 12, 2022 3.5y ago | Christopher L. Jacobs RHouseNew York-27 | ↑bought | Johnson & Johnson JNJ | Nov 8, 2022 34 days to disclose | Good buy·+$2.6K+33.1% +21.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Oct 12, 2022 29 days to disclose | Good buy·+$3.4K+42.2% +20.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2022 3.6y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 12, 2022 50 days to disclose · 5 past 45-day window | Good buy·+$3.2K+39.6% +26.6% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 11, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Sep 12, 2022 29 days to disclose | Good buy·+$3.2K+39.6% +26.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 14, 2022 3.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Johnson & Johnson JNJ | Aug 3, 2022 42 days to disclose | Flat·+0.0% +12.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2022 3.8y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Nov 10, 2021 296 days to disclose · 251 past 45-day window | Missed gain·−$8.7K-38.5% +15.5% vs S&P 500 | $15K-$30K midpoint $22.5K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Jul 15, 2022 26 days to disclose | Good buy·+$2.4K+29.8% +15.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 11, 2022 3.9y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 10, 2022 31 days to disclose | Good buy·+$2.5K+31.8% −51.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2022 4.0y ago | Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | May 11, 2022 29 days to disclose | Good buy·+$2.5K+31.3% +13.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2022 4.0y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Johnson & Johnson JNJ | Apr 25, 2022 45 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 3, 2022 4.0y ago | Cindy Axne —HouseIowa-03 | ↓sold | Johnson & Johnson JNJ | May 12, 2022 22 days to disclose | Flat·+0.0% +16.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 3, 2022 4.0y ago | Cindy Axne —HouseIowa-03 | ↓sold | Johnson & Johnson JNJ | May 4, 2022 30 days to disclose | Flat·+0.0% +11.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 3, 2022 4.0y ago | Cindy Axne —HouseIowa-03 | ↓sold | Johnson & Johnson JNJ | May 4, 2022 30 days to disclose | Flat·+0.0% +11.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 19, 2022 4.1y ago | John H. Rutherford RHouseFlorida-05 | ↓sold | Johnson & Johnson JNJ | Mar 16, 2022 34 days to disclose | Flat·+0.0% +10.8% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 18, 2021 4.6y ago | Robert J. Wittman RHouseVirginia-01 | ↓sold | Johnson & Johnson JNJ | Sep 13, 2021 35 days to disclose | Flat·+0.0% +12.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 18, 2021 4.6y ago | Robert J. Wittman RHouseVirginia-01 | ↓sold | Johnson & Johnson JNJ | Sep 1, 2021 47 days to disclose · 2 past 45-day window | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↓sold | Johnson & Johnson JNJ | Apr 21, 2020 535 days to disclose · 490 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↑bought | Johnson & Johnson JNJ | Feb 13, 2020 603 days to disclose · 558 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↑bought | Johnson & Johnson JNJ | Feb 13, 2020 603 days to disclose · 558 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↑bought | Johnson & Johnson JNJ | Dec 31, 2019 647 days to disclose · 602 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↑bought | Johnson & Johnson JNJ | Jul 18, 2019 813 days to disclose · 768 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↑bought | Johnson & Johnson JNJ | Mar 13, 2019 940 days to disclose · 895 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 7, 2021 30 days to disclose | Good buy·+$3.2K+39.5% +30.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 6, 2017 1387 days to disclose · 1342 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | Blake D. Moore RHouseUtah-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 3, 2021 44 days to disclose | Flat·+0.0% +22.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | Blake D. Moore RHouseUtah-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 26, 2021 113 days to disclose · 68 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | Blake D. Moore RHouseUtah-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 4, 2021 135 days to disclose · 90 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | Blake D. Moore RHouseUtah-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Feb 24, 2021 143 days to disclose · 98 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jun 12, 2021 5.0y ago | Rick W. Allen RHouseGeorgia-12 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | May 13, 2021 30 days to disclose | Missed gain·−$7.6K-33.9% +40.2% vs S&P 500 | $15K-$30K midpoint $22.5K |
May 9, 2021 5.1y ago | Marie Newman —HouseIllinois-03 | ↓sold | Johnson & Johnson JNJ | Apr 23, 2021 16 days to disclose | price pending | $15K-$50K midpoint $32.5K |
May 9, 2021 5.1y ago | Marie Newman —HouseIllinois-03 | ↓sold | Johnson & Johnson JNJ | Apr 1, 2021 38 days to disclose | price pending | $1K-$15K midpoint $8K |
May 6, 2021 5.1y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Apr 30, 2021 6 days to disclose | Good buy·+$9K+39.8% −31.3% vs S&P 500 | $15K-$30K midpoint $22.5K |